Literature DB >> 23002439

Genetic depletion of complement receptors CD21/35 prevents terminal prion disease in a mouse model of chronic wasting disease.

Brady Michel1, Adam Ferguson, Theodore Johnson, Heather Bender, Crystal Meyerett-Reid, Bruce Pulford, Adriana von Teichman, Davis Seelig, John H Weis, Glenn C Telling, Adriano Aguzzi, Mark D Zabel.   

Abstract

The complement system has been shown to facilitate peripheral prion pathogenesis. Mice lacking complement receptors CD21/35 partially resist terminal prion disease when infected i.p. with mouse-adapted scrapie prions. Chronic wasting disease (CWD) is an emerging prion disease of captive and free-ranging cervid populations that, similar to scrapie, has been shown to involve the immune system, which probably contributes to their relatively facile horizontal and environmental transmission. In this study, we show that mice overexpressing the cervid prion protein and susceptible to CWD (Tg(cerPrP)5037 mice) but lack CD21/35 expression completely resist clinical CWD upon peripheral infection. CD21/35-deficient Tg5037 mice exhibit greatly impaired splenic prion accumulation and replication throughout disease, similar to CD21/35-deficient murine prion protein mice infected with mouse scrapie. TgA5037;CD21/35(-/-) mice exhibited little or no neuropathology and deposition of misfolded, protease-resistant prion protein associated with CWD. CD21/35 translocate to lipid rafts and mediates a strong germinal center response to prion infection that we propose provides the optimal environment for prion accumulation and replication. We further propose a potential role for CD21/35 in selecting prion quasi-species present in prion strains that may exhibit differential zoonotic potential compared with the parental strains.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23002439      PMCID: PMC3478448          DOI: 10.4049/jimmunol.1201579

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

Review 1.  Floating the raft hypothesis: lipid rafts play a role in immune cell activation.

Authors:  A Cherukuri; M Dykstra; S K Pierce
Journal:  Immunity       Date:  2001-06       Impact factor: 31.745

2.  Dependence of germinal center B cells on expression of CD21/CD35 for survival.

Authors:  M B Fischer; S Goerg; L Shen; A P Prodeus; C C Goodnow; G Kelsoe; M C Carroll
Journal:  Science       Date:  1998-04-24       Impact factor: 47.728

3.  Prions in skeletal muscle.

Authors:  Patrick J Bosque; Chongsuk Ryou; Glenn Telling; David Peretz; Giuseppe Legname; Stephen J DeArmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

4.  Scrapie replication in lymphoid tissues depends on prion protein-expressing follicular dendritic cells.

Authors:  K L Brown; K Stewart; D L Ritchie; N A Mabbott; A Williams; H Fraser; W I Morrison; M E Bruce
Journal:  Nat Med       Date:  1999-11       Impact factor: 53.440

Review 5.  Cell-specific regulation of the CD21 gene.

Authors:  M D Zabel; J H Weis
Journal:  Int Immunopharmacol       Date:  2001-03       Impact factor: 4.932

6.  Impaired prion replication in spleens of mice lacking functional follicular dendritic cells.

Authors:  F Montrasio; R Frigg; M Glatzel; M A Klein; F Mackay; A Aguzzi; C Weissmann
Journal:  Science       Date:  2000-05-19       Impact factor: 47.728

7.  Regulation of the B cell response to T-dependent antigens by classical pathway complement.

Authors:  M B Fischer; M Ma; S Goerg; X Zhou; J Xia; O Finco; S Han; G Kelsoe; R G Howard; T L Rothstein; E Kremmer; F S Rosen; M C Carroll
Journal:  J Immunol       Date:  1996-07-15       Impact factor: 5.422

8.  Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie.

Authors:  N A Mabbott; M E Bruce; M Botto; M J Walport; M B Pepys
Journal:  Nat Med       Date:  2001-04       Impact factor: 53.440

9.  Complement facilitates early prion pathogenesis.

Authors:  M A Klein; P S Kaeser; P Schwarz; H Weyd; I Xenarios; R M Zinkernagel; M C Carroll; J S Verbeek; M Botto; M J Walport; H Molina; U Kalinke; H Acha-Orbea; A Aguzzi
Journal:  Nat Med       Date:  2001-04       Impact factor: 53.440

10.  PrP expression in B lymphocytes is not required for prion neuroinvasion.

Authors:  M A Klein; R Frigg; A J Raeber; E Flechsig; I Hegyi; R M Zinkernagel; C Weissmann; A Aguzzi
Journal:  Nat Med       Date:  1998-12       Impact factor: 53.440

View more
  22 in total

1.  Murine complement receptor 1 is required for germinal center B cell maintenance but not initiation.

Authors:  Luke R Donius; Janis J Weis; John H Weis
Journal:  Immunobiology       Date:  2014-02-25       Impact factor: 3.144

2.  Remarkable Activation of the Complement System and Aberrant Neuronal Localization of the Membrane Attack Complex in the Brain Tissues of Scrapie-Infected Rodents.

Authors:  Yan Lv; Cao Chen; Bao-Yun Zhang; Kang Xiao; Jing Wang; Li-Na Chen; Jing Sun; Chen Gao; Qi Shi; Xiao-Ping Dong
Journal:  Mol Neurobiol       Date:  2014-10-14       Impact factor: 5.590

Review 3.  Let's make microglia great again in neurodegenerative disorders.

Authors:  Marie-Victoire Guillot-Sestier; Terrence Town
Journal:  J Neural Transm (Vienna)       Date:  2017-10-12       Impact factor: 3.575

4.  Prions and lymphoid organs: solved and remaining mysteries.

Authors:  Tracy O'Connor; Adriano Aguzzi
Journal:  Prion       Date:  2013-01-28       Impact factor: 3.931

5.  Complement Regulatory Protein Factor H Is a Soluble Prion Receptor That Potentiates Peripheral Prion Pathogenesis.

Authors:  Sarah J Kane; Taylor K Farley; Elizabeth O Gordon; Joshua Estep; Heather R Bender; Julie A Moreno; Jason Bartz; Glenn C Telling; Matthew C Pickering; Mark D Zabel
Journal:  J Immunol       Date:  2017-10-25       Impact factor: 5.422

Review 6.  The immunobiology of prion diseases.

Authors:  Adriano Aguzzi; Mario Nuvolone; Caihong Zhu
Journal:  Nat Rev Immunol       Date:  2013-11-05       Impact factor: 53.106

7.  Low activity of complement in the cerebrospinal fluid of the patients with various prion diseases.

Authors:  Cao Chen; Yan Lv; Qi Shi; Wei Zhou; Kang Xiao; Jing Sun; Xiao-Dong Yang; Xiao-Ping Dong
Journal:  Infect Dis Poverty       Date:  2016-05-03       Impact factor: 4.520

8.  Analysis of the Putative Role of CR1 in Alzheimer's Disease: Genetic Association, Expression and Function.

Authors:  Maria I Fonseca; Shuhui Chu; Aimee L Pierce; William D Brubaker; Richard E Hauhart; Diego Mastroeni; Elizabeth V Clarke; Joseph Rogers; John P Atkinson; Andrea J Tenner
Journal:  PLoS One       Date:  2016-02-25       Impact factor: 3.240

Review 9.  Cellular and Molecular Mechanisms of Prion Disease.

Authors:  Christina J Sigurdson; Jason C Bartz; Markus Glatzel
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 32.350

10.  The Priority position paper: Protecting Europe's food chain from prions.

Authors:  Jesús R Requena; Krister Kristensson; Carsten Korth; Chiara Zurzolo; Marion Simmons; Patricia Aguilar-Calvo; Adriano Aguzzi; Olivier Andreoletti; Sylvie L Benestad; Reinhard Böhm; Karen Brown; Byron Calgua; José Antonio Del Río; Juan Carlos Espinosa; Rosina Girones; Sue Godsave; Ludwig E Hoelzle; Michael R Knittler; Franziska Kuhn; Giuseppe Legname; Paul Laeven; Neil Mabbott; Eva Mitrova; Andreas Müller-Schiffmann; Mario Nuvolone; Peter J Peters; Alex Raeber; Klaus Roth; Matthias Schmitz; Björn Schroeder; Tiziana Sonati; Lothar Stitz; Albert Taraboulos; Juan María Torres; Zheng-Xin Yan; Inga Zerr
Journal:  Prion       Date:  2016-05-03       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.